Quick Answer
CNBX Pharmaceuticals Inc. reported Cash And Cash Equivalents At Carrying Value of $15.1 thousand for the year ending 2025.
- CNBX Pharmaceuticals Inc. showed a decrease of -42.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 1, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $15.1 thousand | Fiscal year 2024: $26.4 thousand | Fiscal year 2023: $129.7 thousand | Fiscal year 2022: $117.5 thousand | Fiscal year 2021: $1.39 million | Fiscal year 2020: $777.6 thousand | Fiscal year 2019: $266.0 thousand | Fiscal year 2018: $1.39 million | Fiscal year 2017: $1.39 million | Fiscal year 2016: $19.1 thousand | Fiscal year 2015: $25.2 thousand | Fiscal year 2014: $98.8 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: